Absolute Return Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Absolute Return Capital's VRTX Position: Q3 2014 in Review
Absolute Return Capital sold out of Vertex Pharmaceuticals (VRTX) in Q3 2014, closing a stake of 148,259 shares — an estimated $14M sold.
Absolute Return Capital first reported a position in VRTX in Q1 2014 and held it in 2 quarters. The position peaked at $14M in Q2 2014. 430 funds tracked by Wall St. Rank hold VRTX as of Q3 2014.
- Absolute Return Capital reported no remaining Vertex Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
- Absolute Return Capital sold 148,259 Vertex Pharmaceuticals shares in Q3 2014, an estimated $14M.
- Absolute Return Capital first reported a position in Vertex Pharmaceuticals in Q1 2014 and held it in 2 quarters.
- Absolute Return Capital's Vertex Pharmaceuticals position peaked at $14M in Q2 2014.
- 430 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2014.
Based on Absolute Return Capital's 13F filing for Q3 2014, filed 14 Nov 2014.